AR219531A1 - Procedimiento para preparar el isomero dextrogiro de un compuesto de espirohidantoina asimetrica - Google Patents

Procedimiento para preparar el isomero dextrogiro de un compuesto de espirohidantoina asimetrica

Info

Publication number
AR219531A1
AR219531A1 AR272227A AR27222778A AR219531A1 AR 219531 A1 AR219531 A1 AR 219531A1 AR 272227 A AR272227 A AR 272227A AR 27222778 A AR27222778 A AR 27222778A AR 219531 A1 AR219531 A1 AR 219531A1
Authority
AR
Argentina
Prior art keywords
spyrohydantoine
dextrogiro
isomer
preparing
procedure
Prior art date
Application number
AR272227A
Other languages
English (en)
Spanish (es)
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of AR219531A1 publication Critical patent/AR219531A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/10—Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
AR272227A 1977-05-23 1978-05-18 Procedimiento para preparar el isomero dextrogiro de un compuesto de espirohidantoina asimetrica AR219531A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/799,586 US4130714A (en) 1977-05-23 1977-05-23 Hydantoin therapeutic agents

Publications (1)

Publication Number Publication Date
AR219531A1 true AR219531A1 (es) 1980-08-29

Family

ID=25176274

Family Applications (1)

Application Number Title Priority Date Filing Date
AR272227A AR219531A1 (es) 1977-05-23 1978-05-18 Procedimiento para preparar el isomero dextrogiro de un compuesto de espirohidantoina asimetrica

Country Status (37)

Country Link
US (1) US4130714A (de)
JP (1) JPS6035350B2 (de)
AR (1) AR219531A1 (de)
AT (1) AT357170B (de)
AU (1) AU499518B1 (de)
BE (1) BE867248A (de)
CA (1) CA1088073A (de)
CH (1) CH631455A5 (de)
CS (1) CS200550B2 (de)
DD (1) DD137107A5 (de)
DE (2) DE2858042C2 (de)
DK (1) DK147941C (de)
EG (1) EG13691A (de)
ES (1) ES470070A1 (de)
FI (1) FI62838C (de)
FR (1) FR2392024A1 (de)
GB (1) GB1572688A (de)
GR (1) GR68694B (de)
HK (1) HK53981A (de)
HU (1) HU177718B (de)
IE (1) IE47273B1 (de)
IL (1) IL54754A (de)
IN (1) IN147854B (de)
IT (1) IT1096306B (de)
KE (1) KE3168A (de)
LU (1) LU79685A1 (de)
MY (1) MY8200156A (de)
NL (1) NL7804158A (de)
NO (1) NO150206C (de)
NZ (1) NZ187334A (de)
PH (1) PH13828A (de)
PL (1) PL110460B1 (de)
PT (1) PT68071B (de)
SE (1) SE437375B (de)
SU (1) SU873885A3 (de)
YU (1) YU40829B (de)
ZA (1) ZA782919B (de)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1088945A (en) * 1976-10-18 1980-11-04 Pfizer Limited Hydantoin derivatives as therapeutic agents
US4181728A (en) * 1978-11-16 1980-01-01 Pfizer Inc. Spiro-polycyclicimidazolidinedione derivatives
US4181729A (en) * 1979-03-21 1980-01-01 Pfizer Inc. Phenyl or phenoxy substituted spiro-imidazolidinedione derivatives
US4210667A (en) * 1979-04-19 1980-07-01 Pfizer Inc. Pharmaceutical preparations containing coumarin carboxylic acid derivatives
AU532110B2 (en) * 1979-11-13 1983-09-15 Ici Ltd. Spiro(imidazolidine-4,3:-indoline)-2,2:5-trione derivatives
US4248882A (en) * 1980-02-12 1981-02-03 Pfizer Inc. Treating diabetes-associated complications with hydantoin amines
US4286098A (en) * 1980-03-28 1981-08-25 Pfizer Inc. Process for the preparation of chiral hydantoins
JPS5745185A (en) * 1980-07-21 1982-03-13 Eisai Co Ltd Hydantoin derivative and its preparation
US4419521A (en) * 1981-11-12 1983-12-06 Pfizer Inc. 6-Halo-4-chromanamines useful as intermediates to make chiral hydantoins
JPS58124788A (ja) * 1982-01-20 1983-07-25 Eisai Co Ltd 光学活性ヒダントイン誘導体，その製造方法ならびにそれを含有する治療用薬剤
US4436745A (en) 1982-04-15 1984-03-13 Alcon Laboratories, Inc. Method of inhibiting aldose reductase activity
US4540700A (en) * 1982-04-15 1985-09-10 Alcon Laboratories, Inc. Treatment of diabetic complications with certain spiro-imidazolidine-diones
US4438272A (en) 1982-04-15 1984-03-20 Alcon Laboratories, Inc. Spiro-(fluoren-9,4'-imidazolidine)-2',5'-diones
US4464385A (en) * 1982-04-15 1984-08-07 Alcon Laboratories, Inc. Treatment of diabetic complications with hydantoins
US4431828A (en) * 1982-11-10 1984-02-14 Pfizer Inc. Regeneration of 6-fluoro-4-chromanone from by-products in the synthesis of sorbinil
US4528387A (en) * 1982-11-10 1985-07-09 Pfizer Inc. Sorbinil by optical resolution of precursor 6-fluoro-4-ureidochroman-4-carboxylic acid
US4556670A (en) * 1982-12-06 1985-12-03 Pfizer Inc. Spiro-3-hetero-azolones for treatment of diabetic complications
US4474967A (en) * 1983-04-27 1984-10-02 Pfizer Inc. 8-Deutero and 8-tritio-substituted derivatives of D-4S-6-fluoro-spiro-[chroman-4,4'-imidazolidine]-2',5'-dione
US4537892A (en) * 1983-09-14 1985-08-27 Alcon Laboratories, Inc. Spiro-tricyclicaromatic succinimide derivatives as inhibitors of aldose reductase
US5153211A (en) * 1983-09-14 1992-10-06 Alcon Laboratories, Inc. Spiro-tricyclicaromatic succinimide derivatives as inhibitors of aldose reductase
DE3561198D1 (en) * 1984-03-23 1988-01-28 Pfizer Spiro-indenes and spiro-1,2-dihydro-naphthalenes for treatment of diabetic complications
US4717725A (en) * 1984-04-11 1988-01-05 Alcon Laboratories, Inc. Ophthalmic wound healing with aldose reductase inhibitors
US4600717A (en) * 1984-04-11 1986-07-15 Alcon Laboratories, Inc. Aldose reductase inhibitors useful in ophthalmic wound healing
JPH06772B2 (ja) * 1984-07-09 1994-01-05 鐘淵化学工業株式会社 ３―（４―フルオロフエノキシ）プロピオニトリルを用いる６―フルオロ―４―クロマノンの製造法
US4680306A (en) * 1984-07-20 1987-07-14 Pfizer Inc. Sprio-imidazolones for treatment of diabetes complications
US4656169A (en) * 1984-08-14 1987-04-07 Pfizer Inc. Tetracyclic spiro-hydantoin aldose reductase inhibitors and compositions
DE3565105D1 (en) * 1984-08-20 1988-10-27 Pfizer Process for the production as asymmetric hydantoins
US4620019A (en) * 1984-08-23 1986-10-28 Pfizer Inc. S-6-fluoro-4-aminochroman-4-carboxylic acid derivatives useful as intermediates for sorbinil
US4609663A (en) * 1984-09-11 1986-09-02 Alcon Laboratories, Inc. Aldose reductase inhibitors useful in glaucoma therapy
US4551542A (en) * 1984-09-26 1985-11-05 Pfizer Inc. Regeneration of 6-fluoro-4-chromanone from 6-fluoro-4-ureidochroman-4-carboxylic acid
US4966911A (en) * 1984-11-20 1990-10-30 Washington Research Foundation Immunoregulatory agents
US5340829A (en) * 1984-11-20 1994-08-23 Washington Research Foundation Immunoregulatory agents
JPS61200991A (ja) * 1985-03-04 1986-09-05 Sanwa Kagaku Kenkyusho:Kk スピロ―３―ヘテロアゾリジン化合物、その製法及びそれを有効成分とする糖尿病合併症の予防及び治療剤
WO1986007353A1 (en) 1985-06-14 1986-12-18 Pfizer Inc. Intermediate in the production of an asymmetric hydantoin
JPS627654U (de) * 1985-06-26 1987-01-17
US4853410A (en) * 1986-01-17 1989-08-01 Pfizer Inc. Hydroxyacetic acid derivatives for the treatment of diabetic complications
JPS6357588A (ja) * 1986-08-28 1988-03-12 Sanwa Kagaku Kenkyusho Co Ltd ヒダントイン誘導体、その塩並びに該化合物を有効成分とする糖尿病合併症の予防及び治療剤
WO1988006887A1 (en) * 1987-03-20 1988-09-22 Alcon Laboratories, Inc. Use of aldose reductase inhibitors to enhance insulin sensitivity in diabetes mellitus
US4841079A (en) * 1987-08-07 1989-06-20 Pfizer, Inc. Process for the production of asymmetric hydantoins
US4952694A (en) * 1988-07-27 1990-08-28 Pfizer Inc. Novel resolution process for racemic spiro-hydantoins
US5006657A (en) * 1988-07-27 1991-04-09 Pfizer Inc. Intermediates in a resolution process for racemic spiro hydantoins
AU617541B2 (en) * 1988-10-20 1991-11-28 Wyeth Spiro-isoquinoline-pyrrolidine tetrones and analogs thereof useful as aldose reductase inhibitors
EP0536119A4 (en) * 1989-02-10 1993-08-04 Washington Research Foundation Immunoregulatory agents
US4980357A (en) * 1990-03-01 1990-12-25 Pfizer Inc. Azolidinedione derivatives
US5039672A (en) * 1990-04-05 1991-08-13 Pfizer Inc. Heterocyclic compounds as aldose reductase inhibitors
US5236945A (en) * 1990-06-11 1993-08-17 Pfizer Inc. 1H-indazole-3-acetic acids as aldose reductase inhibitors
US5206367A (en) * 1992-02-18 1993-04-27 Pfizer Inc. Preparation of optically active spiro-hydantoins
CA2145640C (en) * 1992-09-28 2001-01-30 Banavara L. Mylari Substituted pyrimidines for control of diabetic complications
US5521208A (en) * 1993-07-29 1996-05-28 Alcon Laboratories, Inc. Compositions and methods for the treatment of the metabolically impaired and for improved compliance
ES2276460T3 (es) * 1997-04-15 2007-06-16 Csir Extractos de plantas que tienen actividad supresora del apetito.
GB2355657B (en) * 1999-10-27 2004-07-28 Phytopharm Plc Inhibitors Of Gastric Acid Secretion
GB2363985B (en) * 2000-06-30 2004-09-29 Phytopharm Plc Extracts,compounds & pharmaceutical compositions having anti-diabetic activity and their use
EE200300249A (et) 2000-11-30 2003-10-15 Pfizer Products Inc. GABA agonistide ja aldoosreduktaasi inhibiitoritekombinatsioon
US20110092566A1 (en) * 2004-11-19 2011-04-21 Srivastava Satish K Treatment of cancer with aldose reductase inhibitors
US8158667B2 (en) 2006-08-21 2012-04-17 Kador Peter F Topical treatment of cataracts in dogs
ATE518544T1 (de) 2007-03-12 2011-08-15 Zadec Aps Rotbusch-extrakt gegen diabetes
EP2139330B1 (de) 2007-03-23 2014-09-24 The Board of Regents of The University of Texas System Verfahren mit aldose-reduktase-inhibitoren
US20090270490A1 (en) * 2008-04-24 2009-10-29 The Board Of Regents Of The University Of Texas System Methods involving aldose reductase inhibition
WO2012088525A2 (en) 2010-12-23 2012-06-28 The Board Of Regents Of The University Of Texas System Methods for treating copd
UA118035C2 (uk) * 2013-10-07 2018-11-12 Сінгента Партісіпейшнс Аг Гербіцидні сполуки

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2683718A (en) * 1952-01-11 1954-07-13 Searle & Co Spiro-[xanthene-9, 4'-imidazolidine]-2, 5-dione
DE1135915B (de) * 1961-06-29 1962-09-06 Asta Werke Ag Chem Fab Verfahren zur Herstellung neuer, antikonvulsiv wirksamer Spirohydantoine
CA1088945A (en) * 1976-10-18 1980-11-04 Pfizer Limited Hydantoin derivatives as therapeutic agents

Also Published As

Publication number Publication date
JPS53144575A (en) 1978-12-15
NO150206B (no) 1984-05-28
SU873885A3 (ru) 1981-10-15
PL206826A1 (pl) 1979-04-23
PL110460B1 (en) 1980-07-31
CS200550B2 (en) 1980-09-15
DE2821966C2 (de) 1983-06-01
AT357170B (de) 1980-06-25
YU40829B (en) 1986-06-30
FR2392024B1 (de) 1981-07-24
BE867248A (fr) 1978-11-20
DE2821966A1 (de) 1978-11-30
HU177718B (en) 1981-12-28
DK226778A (da) 1978-11-24
AU499518B1 (en) 1979-04-26
DK147941C (da) 1985-08-26
IE47273B1 (en) 1984-02-08
PH13828A (en) 1980-10-07
CA1088073A (en) 1980-10-21
IT7823672A0 (it) 1978-05-22
IL54754A (en) 1982-04-30
JPS6035350B2 (ja) 1985-08-14
DE2858042C2 (de) 1983-11-24
FI62838C (fi) 1983-03-10
FR2392024A1 (fr) 1978-12-22
NO781769L (no) 1978-11-24
LU79685A1 (fr) 1979-12-06
EG13691A (en) 1982-12-31
US4130714A (en) 1978-12-19
ES470070A1 (es) 1979-01-01
DK147941B (da) 1985-01-14
CH631455A5 (fr) 1982-08-13
ZA782919B (en) 1979-06-27
MY8200156A (en) 1982-12-31
SE437375B (sv) 1985-02-25
FI62838B (fi) 1982-11-30
NL7804158A (nl) 1978-11-27
GR68694B (de) 1982-02-01
PT68071B (en) 1979-10-26
IT1096306B (it) 1985-08-26
DD137107A5 (de) 1979-08-15
NO150206C (no) 1984-09-05
KE3168A (en) 1981-11-06
IL54754A0 (en) 1978-07-31
IE781015L (en) 1978-11-23
ATA365378A (de) 1979-11-15
PT68071A (en) 1978-06-01
GB1572688A (en) 1980-07-30
FI781613A (fi) 1978-11-24
YU116978A (en) 1983-02-28
NZ187334A (en) 1984-04-27
SE7803626L (sv) 1978-11-24
IN147854B (de) 1980-07-19
HK53981A (en) 1981-11-13

Similar Documents

Publication Publication Date Title
AR219531A1 (es) Procedimiento para preparar el isomero dextrogiro de un compuesto de espirohidantoina asimetrica
AR222796A1 (es) Un procedimiento para la preparacion de compuestos 2-fenil-3-benzoil-benzotiofeno
ES487381A0 (es) Un procedimiento para la preparacion de un compuesto de guanidinotiazol
MX148972A (es) Procedimiento mejorado para la aplicacion de un revestimiento decorativo
MX5172E (es) Procedimiento para preparar un isomero optico de un compuesto de hexahidrodibenzopiranona
ES489222A0 (es) Un procedimiento para preparar un compuesto de guanidinotia-zol
AR225918A1 (es) Un procedimiento para producir derivados de piran-4-ona y compuesto intermediario utilizado en el mismo
MX147874A (es) Procedimiento para preparar compuestos 2-fenoxi-5-trifluorometilpiridina
ES497366A0 (es) Un procedimiento para la preparacion de nuevos compuestos de mercaptoorganosiloxano.
ES493846A0 (es) Un procedimiento para la preparacion de nuevos compuestos oligolipidos.
ES499243A0 (es) Un procedimiento para la preparacion de un compuesto de ce- falosporina
AR226127A1 (es) Procedimiento para producir un compuesto de piran-4-ona
AR207664A1 (es) Un procedimiento para la preparacion de nuevos compuestos de 6-metil-8-(substituida)metilergolina
ES499957A0 (es) Un procedimiento para la preparacion de compuestos heteroci-clicos
ES491728A0 (es) Un procedimiento para la preparacion de derivados de aceto- fenona substituidos
MX5142E (es) Procedimiento mejorado para preparar un compuesto de cefalosporina
AR210207A1 (es) Un procedimiento para la preparacion de nuevas nicotinoilamino triacinas
ES496190A0 (es) Un procedimiento para preparar un compuesto en racimo de al-coxisilano
AR210162A1 (es) Procedimiento para la preparacion de un 2-alquilindano
IT1098369B (it) Procedimento per la preparazione di un ciclopentendione
MX5827E (es) Procedimiento para preparar el carbanion de la papaverina
AR221844A1 (es) Un procedimiento para la fabricacion de un derivado de 1-hidroxifenoxi-3-ureidoalquilamino-2 propanol
AR226306A1 (es) Procedimiento para la preparacion de un compuesto de dihalovinilo
ES481213A0 (es) Un procedimiento para preparar benzoxepinas
MX4902E (es) Procedimiento para la preparacion de un ester diespiro-ciclopropancarboxilico